ReviewSynthetic and systems biotechnology2016
Synthetic biology in the UK - An outline of plans and progress.
Review in Synthetic and systems biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Synthetic Biology of Plants and Microbes for Agriculture, Environment, and Future Applications.Chemical reviews · 2026Review
- Engineering biology and automation-Replicability as a design principle.Engineering biology · 2024Review
- Public biofoundries as innovation intermediaries: the integration of translation, sustainability, and responsibility.The Journal of technology transfer · 2024Article
- From qualitative to quantitative: the state of the art and challenges for plant synthetic biology.Quantitative biology (Beijing, China) · 2023Review
- Design of Four Small-Molecule-Inducible Systems in the Yeast Chromosome, Applied to Optimize Terpene Biosynthesis.ACS synthetic biology · 2023Article
- Engineering the expression of plant secondary metabolites-genistein and scutellarin through an efficient transient production platform inFrontiers in plant science · 2022Article
- Synthetic biology in Europe: current community landscape and future perspectives.Biotechnology notes (Amsterdam, Netherlands) · 2022Article
- De novo synthesis of synthetic biology ecosystem in Slovakia: Challenges and opportunities.Biotechnology notes (Amsterdam, Netherlands) · 2022Article
- Article
- Developing synthetic biology for industrial biotechnology applications.Biochemical Society transactions · 2020Review
- Private and public values of innovation: A patent analysis of synthetic biology.Research policy · 2020Article
- Plant Biosystems Design for a Carbon-Neutral Bioeconomy.Biodesign research · 2020Review
- Aligning sustainability assessment with responsible research and innovation: Towards a framework for Constructive Sustainability Assessment.Sustainable production and consumption · 2019Article
- Anticipating governance challenges in synthetic biology: Insights from biosynthetic menthol.Technological forecasting and social change · 2019Article
- Developing a graduate training program in Synthetic Biology: SynBioCDT.Synthetic biology (Oxford, England) · 2019Article
- A living foundry for Synthetic Biological Materials: A synthetic biology roadmap to new advanced materials.Synthetic and systems biotechnology · 2018Review
- Scaling up genetic circuit design for cellular computing: advances and prospects.Natural computing · 2018Article
- Synthetic biology in China, UK and US.Synthetic and systems biotechnology · 2016Article
- Tracking the emergence of synthetic biology.ScientometricsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthetic biology is capable of delivering new solutions to key challenges spanning the bioeconomy, both nationally and internationally. Recognising this significant potential and the associated need to facilitate its translation and commercialisation the UK government commissioned the production of a national Synthetic Biology Roadmap in 2011, and subsequently provided crucial support to assist its implementation. Critical infrastructural investments have been made, and important strides made towards the development of an effectively connected community of practitioners and interest groups. A number of Synthetic Biology Research Centres, DNA Synthesis Foundries, a Centre for Doctoral Training, and an Innovation Knowledge Centre have been established, creating a nationally distributed and integrated network of complementary facilities and expertise. The UK Synthetic Biology Leadership Council published a UK Synthetic Biology Strategic Plan in 2016, increasing focus on the processes of translation and commercialisation. Over 50 start-ups, SMEs and larger companies are actively engaged in synthetic biology in the UK, and inward investments are starting to flow. Together these initiatives provide an important foundation for stimulating innovation, actively contributing to international research and development partnerships, and helping deliver useful benefits from synthetic biology in response to local and global needs and challenges.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.